A new paradigm for generative AI drug discovery: more accurate shots on a much wider goal | TPM podcast #47
Move Fast and Try Not to Break Things: AI [...]
Move Fast and Try Not to Break Things: AI [...]
Abstract:Disease progression is closely linked to shifts in the [...]
At the end of May, Genialis CEO Rafael Rosengarten, [...]
KRAS mutations are among the most prevalent oncogenic drivers [...]
Tempus’ live webinar featuring Rafael Rosengarten [...]
New results from translational, clinical, and real-world studies showcase [...]
Schedule a meeting Genialis™ Supermodel - [...]
KRAS mutations drive approximately 25% of human cancers, resulting [...]
The WEE1 kinase is a central regulator of G2/M [...]
"In cancer treatment, a simple yes or no isn’t [...]